Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Focus Cayman Islands.
Press releases published on June 25, 2025
Global mRNA Synthesis and Manufacturing Market to Increase at a Steady Growth Rate of ~4% by 2032 | DelveInsight
GlobeNewswire
·
June 25, 2025
New York, USA, June 25, 2025 (GLOBE NEWSWIRE) -- Global mRNA Synthesis and Manufacturing Market to Increase at a Steady Growth Rate of ~4% by 2032 | DelveInsight The growing incidence of infectious diseases, cancer, and chronic illnesses has substantially …
CHESS Health Rewards Engine: A Better Way to Fight Stimulant Crisis Across Colorado
GlobeNewswire
·
June 25, 2025
Rochester, New York, June 25, 2025 (GLOBE NEWSWIRE) -- CHESS Health is partnering with Porch Light HealthⓇ (PLH) to offer its innovative, automated contingency management Rewards Engine for treating individuals with substance use disorder (SUD). PLH’s …
Gold H2 Delivers First Successful Subsurface Bio-Stimulated Hydrogen Production Field Trial
GlobeNewswire
·
June 25, 2025
HOUSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Gold H2, a climate tech energy company, today announced the successful completion of the world’s first field trial demonstrating subsurface bio-stimulated hydrogen production. Conducted in a legacy oilfield in …
Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance
GlobeNewswire
·
June 25, 2025
Saint-Herblain (France), June 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the shareholders at its Annual General …
Valneva annonce l’approbation des résolutions présentées à son Assemblée Générale annuelle et confirme ses perspectives financières 2025
GlobeNewswire
·
June 25, 2025
Saint-Herblain (France), le 25 juin 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que toutes les résolutions recommandées par son conseil d’administration ont été approuvées par les …
Dr. Anosh Ahmed Announces Major Expansion of COVID Testing Contracts Across U.S. and International Markets
GlobeNewswire
·
June 25, 2025
CHICAGO, June 25, 2025 (GLOBE NEWSWIRE) -- Dr. Anosh Ahmed announces an expansion of his COVID-19 testing services, with new COVID testing contracts now secured and under negotiation across the United States and in key international markets. The initiative …
OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium
GlobeNewswire
·
June 25, 2025
MIAMI, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) today announced its participation in the 3rd Annual Piper Sandler Obesity Symposium being held virtually on June 26, 2025. Management will be participating in a fireside discussion …
Ernst & Young Names USOSM’s Richard Hall an Entrepreneur Of The Year 2025 Southwest Award Winner
GlobeNewswire
·
June 25, 2025
IRVING, Texas, June 25, 2025 (GLOBE NEWSWIRE) -- Ernst …
Safe Legal Steroid Alternatives New Formulation by CrazyBulk: Closest Supplements to Steroids Legally Available In USA
GlobeNewswire
·
June 25, 2025
New York City, June 25, 2025 (GLOBE NEWSWIRE) -- In a significant step forward for the fitness and bodybuilding community, CrazyBulk, a global leader in advanced sports nutrition, is proud to announce the official launch and expanded availability of its “ …
DBal Max Introduces Legal Dianabol Pills for Muscle Growth: A Safe Steroid Now Available in USA
GlobeNewswire
·
June 25, 2025
London, UK, June 25, 2025 (GLOBE NEWSWIRE) -- In a landmark move set to redefine the muscle-building supplement industry, DBal Max today announced the official launch of its legal Dianabol pills in the USA—a scientifically-formulated, safe alternative to …
Dr. Anosh Ahmed Expands National and International COVID Testing Operations with Renewed Emphasis on Compliance and Fraud Prevention
GlobeNewswire
·
June 25, 2025
Chicago, Illinois, June 25, 2025 (GLOBE NEWSWIRE) -- Dr. Anosh Ahmed announces the expansion of his COVID-19 testing operations across the United States and internationally, building on his proven record of delivering high-quality testing services with a …
Lifeward Announces Pricing of $2.6 Million Public Offering
GlobeNewswire
·
June 25, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or …
Aprea Reports Anti-Proliferative Results and Promising Early-Stage Clinical Data for Next-Generation WEE1 Inhibitor, APR-1051, in HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Collaboration with MD Anderson Cancer Center
GlobeNewswire
·
June 25, 2025
Preclinical data demonstrate potent single-agent and combination effects in head and neck squamous cell carcinoma (HNSCC) models, including synergy with anti–PD-1 therapy Initial Phase 1 clinical update shows early disease control in first HPV+ patient …
Commure Launches Commure Agents – AI Assistants That Fully Automate Physician Workflows
GlobeNewswire
·
June 25, 2025
MOUNTAIN VIEW, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Commure, a leading healthcare technology company, today announced the commercial launch of Commure Agents, AI-powered colleagues built for healthcare. Commure Agents are intelligent, customizable …
Serenity Recovery Network Named Finalist for $100,000 Impact 100 Grant
GlobeNewswire
·
June 25, 2025
CINCINNATI, June 25, 2025 (GLOBE NEWSWIRE) -- Serenity Recovery Network (SRN) is honored to announce its selection as a finalist for a $100,000 grant from Impact 100. This prestigious recognition highlights SRN’s innovative approach to expanding recovery …
Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control
GlobeNewswire
·
June 25, 2025
ATLANTA, June 25, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic …
Akari Therapeutics Releases Virtual Investor “What This Means” Segment Highlighting its Recently Granted India Patent
GlobeNewswire
·
June 25, 2025
Access the “What This Means” segment here BOSTON and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel immuno-oncology payload antibody drug conjugates (ADCs) for the …
INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent
GlobeNewswire
·
June 25, 2025
SARASOTA, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare company focused on the fertility sector, today announced it has received a notice of allowance on a new patent for a …
Celebrating National Sunglasses Day: The Science Behind the Style
GlobeNewswire
·
June 25, 2025
Alexandria, Virginia, June 25, 2025 (GLOBE NEWSWIRE) -- Sunglasses may be a hallmark of personal style, but eyecare professionals and health experts agree: their most important role is protection. In anticipation of National Sunglasses Day celebrations on …
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
GlobeNewswire
·
June 25, 2025
Technology Co-Developed by the U.S. Department of Veterans Affairs and Emory University NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel …